We describe an improved in-vitro procedure for detection of endotoxin in human blood and plasma by use 
Nandan and Brown
describedan improved in vitro pyrogen test for detecting picogram amounts of endotoxin contamination in intravenous fluids by using Limulus amoebocyte lysate (LAL). This improvement is based on the measurement of endotoxin-precipitable protein. When increasing concentrations of purified Escherichia coli endotoxin are added to a constant amount of LAL and the reaction allowed to proceed to completion, there is a proportional increase in the protein precipitated by endotoxin. By measuring the amount of protein precipitated from LAL, it is possible to determine the equivalent E. coli endotoxin concentration in unknown solutions when samples of the unknown are run simultaneously with E. coli endotoxin standards and negative controls. Determination of precipitated protein provides greater sensitivity for endotoxin detection than the gelation method (1) .
Gram-negative infections may be associated with fever, hypotension, and intravascular coagulation (2, 3) . Definitive diagnosis is usually made by identifying
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the organisms on blood cultures, but often the results are not available for several days. All major features of Gram-negative sepsis can be attributed to concurrent endotoxemia.
The presence of endotoxin in blood has been difficult to demonstrate.
Levin et al. (4) described the detection of endotoxin or endotoxin-like materials in the blood of patients with Gram-negative sepsis by means of an in vitro pyrogen test that depends upon the ability of endotoxin to produce gelation of an extract of blood cells (amoebocytes) from the horseshoe crab Limulus polyphemus. They showed that there was a good correlation between the results of the test and the presence of a Gram-negative infection. The lowest concentration of endotoxin detected by this test was reported to be 0.5 gig/liter of human blood, plasma, and serum. Endotoxin added to normal blood lost detectable endotoxin activity when undiluted plasma or serum prepared from such blood samples was compared with saline controls. Coagulation resulted in an additional loss of endotoxin activity. This inhibitory effect could be eliminated almost completely by diluting the serum or plasma with nonpyrogenic water. Extraction of plasma with chloroform forGO mm permitted essentially total analytical recovery of endotoxin that had been added to the whole blood or plasma (4).
Das et al. (5) reported finding appreciable amounts of endotoxin in the platelets of patients with Gramnegative sepsis. In their experiments with normal rabbits, infused sublethal doses of E. coli endotoxin were cleared from the circulation within 10 mm (5) . In thrombocytopenic animals, plasma endotoxin clearance was slow. A platelet/endotoxin interaction appeared to be necessary for the final detoxification of the endotoxin by the reticuloendothelial system. Extracting the platelet fraction for endotoxin was shown to increase the sensitivity of the Limulus test for Gram-negative sepsis. Das et al. (5) performed endotoxin addition and recovery experiments in both human and rabbit platelet rich plasma. After incubation, the endotoxin distributed itself between the cell-free plasma and the platelet mass at and above a concentration of 0.05 mg/liter. At endotoxin concentrations below 0.01 mg/liter, the endotoxin could be detected in the platelet fraction only. 
Materials and Methods

Procedures
Preparation of nonpyrogenic glassware. Pyrogens present in all glassware and syringes were destroyed by dry heat in an oven at 250 #{176}C for 4 h.
Tests were done in 10 X 75 mm Becton-Dickinson, "RTU" culture test tubes as described previously (1) .
Preparation of amoebocyte lysate. Lyophilized vials of Limulus amoebocyte lysate were prepared as describedpreviously (1) . LAL batches 4A and 36A were purified by the chloroform extraction procedure as described by Sullivan and Watson (7) .
Protein determination. Protein was measured by Lowry's method for total protein (8).
Reagents
Magnesium chloride (MgCl2.6H20, 50 mmol/liter) and sodium thioglycolate (9 mmol/liter) were prepared in nonpyrogenic sterile isotonic saline (Travenol Laboratories, Deerfield, Ill. 60015). Working MgC12/thioglycolate solution was prepared by mixing equal volumes of each in a nonpyrogenic flask. Lowry copper reagent was prepared by diluting a 2.0-ml aliquot of the stock solution (5 g of CuSO4-5H20 in 1 liter of 85 mmol/liter potassium tartrate) to 100 ml with sodium carbonate solution (2 g of Na2CO3 in 100 ml of 0.1 mol/liter NaOH). Folin-Ciocalteu phenol reagent was prepared by diluting a 2 mol/liter pre-prepared solution (FisherScientific, Pittsburgh, Pa. 15219) with an equal volume of distilled water. Sodium hydroxide solution (0.75 mol/liter) was prepared by appropriately diluting a 10 mol/liter solution (Fisher Scientific) with distilled water. Chloroform (Mallinckrodt Inc., St. Louis, Mo.) was used as supplied. Collection of human blood. Fresh heparinized venous human blood, 500 ml, from apparently healthy donors was used within 2 h of collection. The blood was drawn tained by centrifugingthe heparinized blood portions (A, B, and C) at 150 X g for 20 mm at 25 ± 2 #{176}C. The total volume of the separated platelet-rich plasma was measured and it was transferred into a nonpyrogenic Erlenmeyer flask. The platelets were lysed, to release the endotoxin contained in the platelet, by adding two parts of nonpyrogenic sterile distilled water (Travenol) to one part of platelet-rich plasma. Whole human blood standard. Portion A was used for the determination of E. coli endotoxin standard curve in whole blood. The E. coli endotoxin solution was added directly to each of six individual A-portions of whole blood to give the endotoxin concentration of 100, 6.25, 0.781, 0.195, 0.049, and 0.012 pg/liter of whole blood. Platelet-rich plasma was then separated and extracted with chloroform.
Standards
Platelet-rich plasma standard. Portion B was used for the determination of E. coli endotoxin standard curve in platelet-rich plasma. E. coli endotoxin solution was added directly to each of six individual portions of platelet-rich plasma to give the initial endotoxin concentration of 100, 6.25, 0.781, 0.195, 0.049, and 0.012 zg/liter of platelet-rich plasma. Platelet-rich plasma was then extracted with chloroform.
Negative control. Portion C was used as the negative control, to determine the basal levels of endotoxin, if present. Platelet-rich plasma was simply extracted with chloroform.
Standard curve without chloroform extraction. The E. coli endotoxin standard curve was also determined in whole blood, platelet-rich plasma, and negative controls before chloroform extraction.
Chloroform extraction. Chloroform extraction (4) was used to remove the inhibitory proteins from the plasmathat had been previously diluted with water to lyse the platelets. One part of chloroform was added to three parts of this diluted plasma. The chloroform and plasma were initially mixed normally for 1 mm. This was followed by 1 h of vigorous mixing at 25 ± 2 #{176}C in a wrist-action shaker. The chloroform/plasma emulsion was separated by centrifugation at 100 X g for 10 mm at 25 ± 2 #{176}C. Upon centrifugation, the emulsion separated into a clear aqueous (top) layer, a middle cloudy layer, and a bottom layer of chloroform containing particulate proteins. Since Levin et al. (4) had earlier demonstrated maximum endotoxin activity in the middle cloudy layer, we used this layer in measuring the blood levels of E. coli equivalent endotoxin in all experiments.
Measurement of endotoxin-precipitated protein.
The test for measurement of endotoxin in the chloroform-extracted plasma (A, B, and C) was performed by placing 0.1 ml of the middle cloudy layer and 0.1 ml of LAL in 10 X 75 mm nonpyrogenic glass test tubes. After gentle mixing, the tubes were incubated in a water bath at 37 #{176}C for one hour and then at room temperature (25 ± 2 #{176}C) for 10 mm. At the end of the incubation period, all tubes were processed for the determination of endotoxin-precipitable protein as follows. The tubes were gentlytapped,to break the clot, if present. All incubated tubes were then centrifuged at 12 350 X g for 10 mm and the supernatant fluid was aspirated. The precipitate was washed with 0.5 ml of nonpyrogenic sterile distilled water. The supernate was aspirated after centrifugation at 12 350 X g for 10 mm. The washed precipitate was dissolvedin 0.2 ml of 0.75 mol/liter NaOH and processed for total protein determination by the Lowry method as described previously (1) . A protein standard curve was run simultaneously, with use of albumin standard. Lowry copper reagent, 1.0 ml, was added to 0.2 ml of protein solution in 0.75 mol/liter NaOH, the mixture was allowed to stand for 10 mm at room temperature (25 ± 2 #{176}C), and 0.1 ml of the Folin-Ciocalteu reagent was then added, immediately mixed, and the reaction mixture was incubated for 30 mm at room temperature.
The final absorbance was measured in a Gilford 300 N spectrophotometer at 500 nm. The concentration of endotoxin in the blood cells was obtained as follows: 
Results
The standard curve (Figure 1) shows the increase in absorbancein response to the increases in E. coli endotoxin concentration with use of a single batch of LAL (batch 4A). Figure 1 shows that the E. coli equivalent endotoxin activity could not be detected in whole blood (portion A) and platelet-rich plasma (B) standards if the in vitro pyrogen test was done before the chloroform extraction procedure. In contrast, removal of the inhibitory proteins from plasma by chloroform extraction made it possibleto repeatedly detect endotoxin concentrations aslow as 195 ng/liter in whole blood (A) and 49 ng/liter in platelet-rich plasma (B). Both whole-blood standards (A) and platelet-rich plasma standards (B) showed similar sensitivity of endotoxin detection at and between the endotoxin concentrations of 195 ng/liter and 100 tg/liter. Absorbances at endotoxin concentration of 12 ng/liter of isotonic saline could be repeatedly differentiated from the negative controls. Both whole blood (A) and platelet-rich plasma (B) standards showed some loss of detectable endotoxin activity at and below endotoxin concentrations of 781 ng/liter when compared with the E. coli standard curve in saline. Table 1 shows the statistical analysis of the sensitivity and reproducibility of endotoxin detection. The data were collected in duplicate and analyzed by the analysis of variance for a two-factor, completely randomized experiment, with endotoxin concentration as one factor and LAL batch as the second factor. Tukey's method (10) of simultaneous pairwise contrasts was used to establish statistically significant differences between the negative controls and the endotoxin concentrations usedin each batch of LAL in each experiment. Table 2 gives the analysis of variance for three batches of LAL run in duplicate at each endotoxin concentration and the negative control. The mean square for error shown in Table 2 provided a pooled estimate of variance for replicate determinations of a fixed unknown on a given day with a single batch of
lysate.
The difference in absorbance between the endotoxin concentrations of 195 ng/liter of whole blood and the negative controls was significant (P <.01) for LAL batches 4A and 36A. The lowest endotoxin concentration that could be detected with LAL batch 24B was 6.25 big/liter of whole blood, but this batch was not purified by Sullivan's (7) chloroform extraction procedure, and this may partly account for its lower potency for endotoxin detection in blood and plasma.
The biological activity of purified E. coli (055:B5) has been reported previously (1) . The lowest concentration of this endotoxin standard in isotonic saline that could be detected in rabbits by the current USP procedure was 98 ng/liter. The in vitro test procedure, when used with lysate batch 4A, repeatedly detected E. coli (055:B5) equivalent endotoxin activity of 12 ng/liter of saline ( Figure 1 ).
Discussion
Detection of endotoxin in human whole blood and plasma by the method based upon the measurement of endotoxin-precipitable protein is considerably more sensitive than are the gelation methods now in use. The analytical recovery of detectable endotoxin in whole blood and plasma was comparable to the endotoxin detection in isotonic saline at and above the endotoxin concentrations of 3.125 ag/liter. However, at and between the endotoxin concentrations of 781 and 49 ng/liter there was some loss of detectable endotoxin activity when compared to the endotoxin activity in saline. The lowest endotoxin concentration detected by this procedure was 49 ng/liter when the E. coli endotoxin was added directly to platelet-rich plasma. The lowest concentration of endotoxin added to human whole blood that could be detected was 195 ng/liter.
Even though this procedure measures the endotoxin precipitable protein, the measurement of precipitate need not be expressed in terms of albumin. The absorbances obtained in response to various endotoxin concentrations provide an entirely independent assay, the results of which did not depend upon the albumin standard curve. As reported earlier (1), the sensitivity and reproducibility of the assay expressed in terms of precipitated protein was entirely comparable to the sensitivity and reproducibility expressed in terms of the absorbances.
The use of platelet-rich plasma in our experiments was based upon the observations of Das et al. (5) that at endotoxin concentrations of 10 ,g/liter or less, endotoxin activity could only be detected in the platelet fraction. Our preliminary experiments indicated that the dilution of one part of platelet-rich plasma with two parts of nonpyrogenic distilled water greatly increased the detectable endotoxin activity as compared to the endotoxin activity in undiluted platelet-rich plasma. This dilution procedure, in addition to lysing the platelets and releasing endotoxin, served to dilute the inhibitors of the endotoxin/LAL reaction. The chloroform extraction procedure of Levin et al. (4, 11) was modified in our studies. The recovery of endotoxin activity was maximum with extraction mixtures containing one part of plasma, two parts of water, and one part of chloroform. Levin used one part of chloroform to four parts of plasma.
The lowest E. coli endotoxin activity detected by Levin et al. (11) was 0.5 tg/liter of human blood, plasma, or serum. The incubation period of LAL/endotoxin mixture was between 4 and 24 h. Das et a!. (5) reported detecting the lowest E. coli endotoxin concentrations (1 pg/liter) in the platelet fraction after incubation periods of 4 to 8 h. Fossard et al. (12) detected E. coli endotoxin concentrations as low as 1 pg/liter of blood after 24-h incubation. Reinhold et al. (6) reported detecting the lowest Serratia marcescens endotoxin activity, 2 pg/liter of plasma. Measurement of endotoxin-precipitable protein enabled us to detect E. coli endotoxin concentrations as low as 49 ng/liter of plasma and 195 ng/liter of whole blood. This procedure therefore provided far greater sensitivity for endotoxin measurement in whole blood and plasma than has hitherto been reported. Another significant advantage of this procedure was the short (60-mm) incubation period required.
In conclusion, the in vitro pyrogen test based upon the determination of endotoxin precipitable protein offers several-fold greater sensitivity for endotoxin measurement in human whole blood and plasma than the gelation methods currently in use. Because the endpoint measurement in this procedure depends on protein precipitation
and not on complete gelation, the method effectively measures endotoxin in reaction mixtures showing gelation as well as in reaction mixtures where complete gelation had not occurred. The sensitivity for endotoxin detection in blood and plasma was maximum with LAL that had been purified by the chloroform-precipitationprocedure.
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